Covid-19
Bloomington facility to help make COVID-19 vaccine

INDIANAPOLIS — A major pharmaceutical company with operations in central Indiana will help make a possible vaccine for the coronavirus.
Catalent has signed an agreement to manufacture Johnson & Johnson’s lead vaccine candidate for COVID-19 in the United States.
The company will use it’s 875,000-square-foot facility in Bloomington for the operation.
Johnson & Johnson has been working on a coronavirus vaccine since January. They hope to start clinical trials by September at the latest. Plans call for Catalent to hire about 300 additional employees in Bloomington to help get the vaccine to Americans.
“We’re happy that we’re able to help the community, and really, I think the employees are very engaged and feel good about the fact that we’re working on something impacts everybody around them,” said Denis Johnson, vice president and general manager of Catalent in Bloomington.
Catalent says they are looking to start the manufacturing process in July with the ability to run around the clock by January.
-
Local News2 weeks ago
In a now-deleted post, Elon Musk refers to Indiana Senator Todd Young as a “deep state puppet”
-
Local News2 weeks ago
Ball State cancels staff training for LGBTQ 101, citing possible new Indiana law
-
Local News2 weeks ago
Governor Braun names an inspector general to investigate mismanagement, waste, and fraud
-
Local News2 weeks ago
A dental practice on Indianapolis’ east side experiences a data breach
-
Local News2 weeks ago
Following a court settlement, the Indiana Department of Health will make terminated pregnancy information available
-
Local News1 week ago
Downtown investments in Indianapolis are expected to yield billions of dollars
-
Local News7 days ago
Governor Braun demands that the project in the Hoosier National Forest be abandoned
-
Local News1 week ago
Innovative strategies used by Bloomington businesses and restaurants to cut down on food waste